E. V. Kuznetsova

Melatonin: Manager of psychosomatic and metabolic disorders in polymorbid cardiovascular pathology

A. Trufanov, K. Markin, V. Polyakova, 2022, Frontiers in Neuroscience.

[Oxidative stress in the pathogenesis of stroke and its correction].

T. Kameneva, M. Martynov, M. Zhuravleva, 2023, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.

Evaluation of the effectiveness of migraine therapy using functional resting MRI with course rhythmic transcranial magnetic stimulation

A. Trufanov, K. Markin, D. Frunza, 2023, Russian neurological journal.

[Results of clinical studies of the efficacy and safety of the use of ethylmethylhydroxypyridine succinate in patients with chronic cerebral ischemia].

T. Kameneva, S. Serebrova, P. Kamchatnov, 2022, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.

Subcortical lesions in various phenotypes of multiple sclerosis and their prognostic significance

A. Trufanov, I. Litvinenko, M. Odinak, 2021, Vestnik nevrologii, psihiatrii i nejrohirurgii (Bulletin of Neurology, Psychiatry and Neurosurgery).

Assessment of progression of Parkinson’s disease using magnetic resonance morphometry

A. Trufanov, I. Litvinenko, M. Odinak, 2022, Russian neurological journal.

[Study of the effect of Unifuzol on cognitive impairment and damage to the hippocampus and cerebral cortex during course administration to rats with bilateral stenosis of the common carotid arteries, causing chronic circulatory failure].

A. Kovalenko, E. Morkovin, D. Kurkin, 2023, Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova.

Economic aspects of the fixed combinations of lipid lowering medicines in group risks patients

T. Kameneva, M. Zhuravleva, M. Frolov, 2023, Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice.